文献速递精神分裂症与精神病性障碍心境障碍

神经营养因子受体激活可挽救Cacna1c单倍不足所致认知与突触异常

Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c.
PubMed 文献 · Mol Psychiatry · 2021-02-17

该研究在大鼠中探讨精神疾病风险基因Cacna1c单拷贝突变对认知、突触和环路表型的影响。Cacna1c+/-大鼠表现出学习忽视非显著刺激的损害,伴随网络振荡失调、海马突触可塑性通路选择性破坏、树突棘Ca2+信号减弱及ERK通路信号下降。使用TrkB/TrkC小分子激动剂激活ERK通路可挽救行为与突触可塑性缺陷。

要点

  • Cacna1c单倍不足导致大鼠学习忽视非显著刺激的损害,该行为改变与精神病相关。
  • Cacna1c+/-大鼠存在学习期网络振荡失调、海马突触可塑性通路选择性破坏及ERK信号下降。
  • TrkB/TrkC激动剂激活ERK通路可挽救Cacna1c+/-大鼠的行为与突触可塑性缺陷。

核心结论

  • CACNA1C遗传变异可通过破坏经验依赖性突触信号和环路活动导致精神疾病相关认知改变。
  • 靶向激活神经营养因子信号通路(BDNF模拟药物)是遗传信息指导的治疗策略,可挽救精神疾病行为异常。

研究设计与样本

  • 研究使用Cacna1c单拷贝突变(Cacna1c+/-)大鼠模型,评估认知、突触和环路表型。

主要发现

  • Cacna1c+/-大鼠在学习忽视非显著刺激方面存在显著损害。
  • Cacna1c+/-大鼠学习期网络振荡失调,海马突触可塑性呈通路选择性破坏。
  • Cacna1c+/-大鼠树突棘Ca2+信号减弱,ERK通路信号下降。
  • TrkB/TrkC小分子激动剂激活ERK通路后,Cacna1c+/-大鼠的行为和突触可塑性缺陷均被挽救。

临床怎么用

  • 靶向激活神经营养因子信号通路可能作为遗传信息指导的治疗策略,用于挽救精神疾病相关行为异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genetic variation in CACNA1C, which encodes the alpha-1 subunit of CaV1.2 L-type voltage-gated calcium channels, is strongly linked to risk for psychiatric disorders including schizophrenia and bipolar disorder. To translate genetics to neurobiological mechanisms and rational therapeutic targets, we investigated the impact of mutations of one copy of Cacna1c on rat cognitive, synaptic and circuit phenotypes implicated by patient studies. We show that rats hemizygous for Cacna1c harbour marked impairments in learning to disregard non-salient stimuli, a behavioural change previously associated with psychosis. This behavioural deficit is accompanied by dys-coordinated network oscillations during learning, pathway-selective disruption of hippocampal synaptic plasticity, attenuated Ca2+ signalling in dendritic spines and decreased signalling through the Extracellular-signal Regulated Kinase (ERK) pathway. Activation of the ERK pathway by a small-molecule agonist of TrkB/TrkC neurotrophin receptors rescued both behavioural and synaptic plasticity deficits in Cacna1c+/- rats. These results map a route through which genetic variation in CACNA1C can disrupt experience-dependent synaptic signalling and circuit activity, culminating in cognitive alterations associated with psychiatric disorders. Our findings highlight targeted activation of neurotrophin signalling pathways with BDNF mimetic drugs as a genetically informed therapeutic approach for rescuing behavioural abnormalities in psychiatric disorder.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Tigaret CM, Lin TE, Morrell ER, et al. Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c. Mol Psychiatry. 2021. PMID: 33597718. doi:10.1038/s41380-020-01001-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。